Liquid Chromatography Mass Spectrometry (LC-MS) Market Report 2026

The liquid chromatography mass spectrometry (lc-ms) market size has grown rapidly in recent years. It will grow from $7.73 billion in 2025 to $8.83 billion in 2026 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to expansion of pharmaceutical r&d, growth in analytical laboratories, rising demand for complex sample analysis, advancements in chromatography systems, increased government research funding.

The liquid chromatography mass spectrometry (lc-ms) market size is expected to see rapid growth in the next few years. It will grow to $14.28 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to precision medicine growth, increasing biologics development, automation of analytical workflows, demand for high-throughput analysis, integration of ai-driven data interpretation. Major trends in the forecast period include growing adoption in drug development, expansion of proteomics and metabolomics, demand for high-sensitivity analytical techniques, integration with advanced data analysis software, increasing use in regulatory testing.

The growing number of clinical trials is expected to drive the liquid chromatography-mass spectrometry (LC-MS) market going forward. Clinical trials involve evaluating new medical treatments, interventions, or therapies in humans to determine their safety and efficacy. The rise in clinical trials is driven by advancements in medical research, the increasing prevalence of chronic diseases, regulatory support and incentives, greater investment in R&D, and the growth of precision medicine. LC-MS supports clinical trials by providing precise and reliable analysis of biological samples, enabling identification and quantification of drugs, metabolites, and biomarkers, which aids in drug efficacy and safety evaluations, pharmacokinetic and pharmacodynamic studies, and personalized medicine approaches. For example, according to ClinicalTrials.gov, a US-based clinical trial registry, 477,234 clinical trials were registered globally in 2023, up from 437,512 trials in 2022. Therefore, the increasing number of clinical trials is propelling the LC-MS market.

Major companies in the LC-MS market are focusing on developing advanced instruments to enhance analytical sensitivity, accuracy, and speed, improving detection and quantification of complex biological and chemical compounds. High-performance LC-MS instruments are designed to deliver exceptional sensitivity, accuracy, and throughput for complex sample analysis. For instance, in June 2024, Thermo Fisher Scientific, a US-based medical device manufacturer, launched Stellar, a high-performance LC-MS instrument. Stellar is designed for highly multiplexed targeted quantitation, combining fast throughput, high sensitivity, and ease of use to advance translational omics research and facilitate more efficient breakthrough discoveries.

In April 2025, Bruker Corporation, a US-based provider of scientific instruments and analytical mass spectrometry systems, acquired a majority stake in RECIPE Chemicals + Instruments GmbH for an undisclosed amount. Through this acquisition, Bruker aims to expand its clinical mass spectrometry capabilities by integrating RECIPE’s diagnostic assay kits and workflows with its LC MS/MS and high-throughput mass spectrometry platforms, providing a comprehensive end-to-end solution for therapeutic drug monitoring and small-molecule diagnostics. RECIPE Chemicals + Instruments GmbH is a Germany-based provider of in vitro diagnostic assay kits for LC MS/MS, HPLC, and ICP MS, including therapeutic drug-monitoring products under its ClinMASS and ClinDART lines.

Major companies operating in the liquid chromatography mass spectrometry (lc-ms) market are Agilent Technologies Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Waters Corporation, Shimadzu Corporation, Bruker Corporation, JEOL Ltd., Hitachi Ltd., PerkinElmer Inc., JASCO Corporation, Phenomenex Inc., GL Sciences Inc., Hamilton Company, Advion Inc., KNAUER Wissenschaftliche Geräte GmbH, VWR International LLC, Sartorius AG, Metrohm AG, Analytik Jena GmbH, CEM Corporation.

North America was the largest region in the liquid chromatography mass spectrometry (LC-MS) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liquid chromatography mass spectrometry (lc-ms) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the liquid chromatography mass spectrometry (lc-ms) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The liquid chromatography mass spectrometry (LC-MS) market consists revenues earned by entities by providing services such as sample preparation, method development and validation, quantitative and qualitative analysis, and biopharmaceutical analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The liquid chromatography mass spectrometry market also includes sales of LC-MS systems, liquid chromatographs, mass spectrometers, solvents, buffers, columns, and sample prep kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.